RE:RE:Mackie ResearchI think the conspiracy theories can be put to rest. Bottom line is sales have been slower than anyone anticipated. Our hope is the J code and ADAP programs accelerate USA sales. Everything else has gone well with reimbursement/access, drug approvals, peer reviewed journal articles, now it's time for TH to show us they can pull this off and maybe exceed the fly by night guidance that has been provided.